Noradrenergic function and HPA axis dysregulation in suicidal behaviour

Psychoneuroendocrinology

Volumn 35, Issue 10, 2010, Pages 1536-1542

  Jokinen, Jussi ^a   Ouda, John ^a   Nordström, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cortisol; CSF MHPG; Depression; Dexamethasone test; HPA axis; Noradrenaline; Suicide; Suicide attempt

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; DEXAMETHASONE; HYDROCORTISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MORTALITY; NORADRENERGIC SYSTEM; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SUICIDAL BEHAVIOR; SURVIVOR; UNIVERSITY HOSPITAL;

CAUSE OF DEATH; COHORT STUDIES; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LOGISTIC MODELS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 78650174895     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.05.008     Document Type: Article

References (40)

1. Agren H., Niklasson F. Suicidal potential in depression: focus on CSF monoamine and purine metabolites. Psychopharmacol. Bull. 1986, 22:656-660.
2. Arango V., Underwood M.D., Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol. Psychiatry 1996, 39:112-120.
3. Bertilsson L. Quantitative mass fragmentography-a valuable tool in clinical pharmacology. Clinical Pharmacology in Psychiatry 1981, 59-72. Elsevier, New York. E. Usdin (Ed.).
4. Boza R.A., Milanes F.J., Llorente M., Reisch J., Slater V.L., Garrigo L. The DST and suicide among depressed alcoholic patients. Am. J. Psychiatry 1988, 145:266-267.
5. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry 2001, 158:748-753.
6. Engström G., Alling C., Blennow K., Regnell G., Traskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur. Neuropsychopharmacol. 1999, 9:399-405.
7. Fukutake M., Hishimoto A., Nishiguchi N., Nushida H., Ueno Y., Shirakawa O., Maeda K. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(6):1428-1433.
8. Galfalvy H., Currier D., Oquendo M.A., Sullivan G., Huang Y.Y., Mann J.J. Lower CSF MHPG predicts short-term risk for suicide attempt. Int. J. Neuropsychopharmacol. 2009, 12(10):1327-1335.
9. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
10. Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 2004, 161:1256-1263.
11. Haukka J., Suominen K., Partonen T., Lönnqvist J. Determinants and outcomes of serious attempted suicide: a nationwide study in Finland 1996-2003. Am. J. Epidemiol. 2008, 167(10):1155-1163.
12. Jokinen J., Carlborg A., Martensson B., Forslund K., Nordstrom A.L., Nordstrom P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res. 2007, 150(3):297-303.
13. Jokinen J., Nordstrom A.L., Nordstrom P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J. Affect. Disord. 2008, 106:145-152.
14. Jokinen J., Nordström P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 2008, 33(10):1387-1393.
15. Jönsson E., Sedvall G., Brené S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol. Psychiatry 1996, 40(10):1032-1043.
16. Kopin I., Gordon E., Jimerson D., Polinsky R. Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 1983, 219:73-75.
17. Lester D. The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry 1992, 25:265-270.
18. Lindqvist D., Isaksson A., Träskman-Bendz L., Brundin L. Salivary cortisol and suicidal behavior-a follow-up study. Psychoneuroendocrinology 2008, 33(8):1061-1068.
19. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int. J. Neuropsychopharmacol. 2006, 21:1-10.
20. Nordström P., Samuelsson M., Åsberg M.M., Traskman-Bendz L., Aberg-Wistedt A., Nordin C., Bertilsson L. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat. Behav. 1994, 24:1-9.
21. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., Overholser J.C. The dexamethasone suppression test and completed suicide. Acta Psychiatr. Scand. 1990, 81:120-125.
22. Ordway G.A., Smith K.S., Haycock J.W. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 1994, 62:680-685.
23. Ordway G.A., Widdowson P.S., Smith K.S., Halaris A. Agonist binding to a2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 1994, 63:617-624.
24. Pandey G.N., Dwivedi Y. Noradrenergic function in suicide. Arch. Suicide Res. 2007, 11:235-246.
25. Persson M.L., Wasserman D., Geijer T., Jönsson E.G., Terenius L. Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Res. 1997, 72(2):73-80.
26. Pfennig A., Kunzel H.E., Kern N., Ising M., Majer M., Fuchs B., Ernst G., Holsboer F., Binder E.B. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol. Psychiatry 2005, 57:336-342.
27. Roy A., Pickar D., De Jong J., Karoum F., Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch. Gen. Psychiatry 1988, 45(9):849-857.
28. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 2007, 12:331-359.
29. Secunda S.K., Cross C.K., Koslow S., Katz M.M., Kocsis J., Maas J.W., Landis H. Biol. Psychiatry 1986, (8-9):756-767.
30. Sequeira A., Mamdani F., Lalovic A., Anguelova M., Lesage A., Seguin M., Chawky N., Desautels A., Turecki G. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res. 2004, 125(2):87-93.
31. Sunnqvist C., Westrin A., Traskman-Bendz L. Suicide attempters: biological stress markers and adverse life events. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258:456-462.
32. Targum S.D., Rosen L., Capodanno A.E. The dexamethasone suppression test in suicidal patients with unipolar depression. Am. J. Psychiatry 1983, 140:877-879.
33. Tidemalm D., Långstrom N.S., Lichtenstein P., Runeson B. Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long-term follow-up. BMJ 2008, 18(337):2205.
34. Träskman-Bendz L., Alling C., Oreland L., Regnell G., Vinge E., Öhman R. Prediction of suicidal behavior from biologic tests. J. Clin. Psychopharmacol. 1992, 12(Suppl.):21-26.
35. Virkkunen M., De Jong J., Bartko J., Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch. Gen. Psychiatry 1989, 46:604-606.
36. WHO World Report on Violence and Health 2002, World Health Organization, Geneva.
37. Yerevanian B.I., Feusner J.D., Koek R.J., Mintz J. The dexamethasone suppression test as a predictor of suicidal behaviour in unipolar depression. J. Affect. Disord. 2004, 83:103-108.
38. Young E.A., Abelson J.L., Cameron O.G. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 2005, 30(8):807-814.
39. Young E.A., Coryell W. Suicide and the hypothalamic-pituitary-adrenal axis. Lancet 2005, 366(9490):959-961.
40. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39(4):561-577.